CRP and osteosarcoma: Hence, the association between systemic inflammatory marker (e.g., NLR, CRP, LMR, GPS, and PLR) levels and the overall survival of patients with osteosarcoma was explored by a meta-analysis, aiming to assess these biomarkers as prognostic factors for overall survival and disease-specific survival.